Literature DB >> 30426732

Postoperative pain after vitreo-retinal surgery is influenced by surgery duration and anesthesia conduction.

Beatrice Loriga1, Alessandro Di Filippo2, Lorenzo Tofani3, Patrizia Signorini1, Tomaso Caporossi4, Francesco Barca4, Angelo R De Gaudio4, Stanislao Rizzo4, Chiara Adembri1.   

Abstract

BACKGROUND: The control of postoperative pain (POP) is a key component of perioperative care. POP after vitreo-retinal surgery (VRS) has been under-investigated, and its incidence remains elusive.
METHODS: In order to assess POP after VRS, the associated risk factors and efficacy of the analgesic protocol in use at our institution, we made a one-year retrospective study on patients undergoing VRS. Patients aged >18 years, ASA Class I-III undergoing VRS entered the study. POP was evaluated by measuring a Numerical Rating Scale (NRS), and analgesic consumption.
RESULTS: A total of 782 patients entered the study. Patients received locoregional (LRA) or general anesthesia (GA) with supplemental block. Twenty-two percent of patients needed analgesics (acetaminophen in 97% of cases), mostly between two and six hours after surgery. The univariate analysis showed a positive association between POP and duration of surgery (P<0.0001) and glaucoma (P=0.04), and a negative association with age (P=0.008), analgesic administration at the end of surgery (P=0.005) and the intraoperative administration of remifentanil for surgery under LRA (P=0.02); sedation to execute the block for LRA did not reduce POP. Patients treated with GA with supplemental block had less pain compared to those treated with LRA with/without remifentanil (P=0.03, P=0.002, respectively). The multivariate analysis confirmed a positive correlation between POP and duration of surgery (P=0.0007) and a negative correlation with the intraoperative remifentanil administration during LRA (P=0.04), and with GA with supplemental block (P=0.01).
CONCLUSIONS: The incidence of POP after VRS is low but not absent, especially for long procedures, it does not require postoperative opioids and can be modified by anesthesiologic choices.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30426732     DOI: 10.23736/S0375-9393.18.13078-1

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  2 in total

1.  Factors affecting sufentanil consumption for intravenous controlled analgesia after hepatectomy: retrospective analysis.

Authors:  Yue Wu; Lina Tian; Chunye Li; Minjun Liu; Shina Qiao; Weibo Zhang; Suming Tian; Gang Chen
Journal:  BMC Anesthesiol       Date:  2021-12-07       Impact factor: 2.217

2.  Preventive Analgesia, Hemodynamic Stability, and Pain in Vitreoretinal Surgery.

Authors:  Michał Jan Stasiowski; Aleksandra Pluta; Anita Lyssek-Boroń; Magdalena Kawka; Lech Krawczyk; Ewa Niewiadomska; Dariusz Dobrowolski; Robert Rejdak; Seweryn Król; Jakub Żak; Izabela Szumera; Anna Missir; Przemysław Jałowiecki; Beniamin Oskar Grabarek
Journal:  Medicina (Kaunas)       Date:  2021-03-12       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.